EN2 oncogenes for cancer diagnosis and treatment.

We are currently developing diagnostic tests which may detect prostate abnormalities at the pre-malignant state years before the onset of cancer. Our therapeutics in development involves blocking the expression of cancer causing proteins and the subsequent re-expression of a naturally occurring component of the immune system to fight cancer. Finally, we are developing novel drugs, antibodies and antibody-drug conjugates to deactivate the cancer causing protein for cancer treatment and/or prevention.